Kappa opioid receptor control of motivated behavior revisited
Open Access
- 13 October 2025
- journal article
- review article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 51 (2) , 383-398
Abstract
Since its discovery, the kappa opioid receptor (KOR) has held the curiosity of basic and clinical researchers across disciplines. Recent advances in technologies for measuring and manipulating KOR activity have poised the field for breakthrough discoveries. As paradigms shift, it is paramount that lessons from the foundational literature are synthesized and passed forward to inform future studies. At the same time, the promise of leveraging the KOR system to improve treatment of neuropsychiatric disorders has thus far failed to materialize, highlighting the need for critical evaluation of whether current frameworks have proven reliable and generalizable. To this end, we review the physiology and pharmacology of KORs and dynorphins and their role in motivated behavior from their discovery through present day. We focus on distinct epochs within the literature and, in parallel sections, present (A) a timeline of major findings leading to the frameworks on which current research is based, and (B) critically revisit the empirical support for specific aspects of these conclusions. In particular, we highlight discrepancies which subvert the canon that KORs’ essential function is to encode negative affective states. By synthesizing the foundational literature and calling into question long-standing theories of KOR function, we hope to highlight the ideas that should remain foundational moving forward and identify areas that may benefit from reconceptualization.Keywords
Funding Information
- National Institute on Drug Abuse (DA056196)
- National Institute on Drug Abuse (DA04510)
- National Institute on Alcohol Abuse and Alcoholism (AA029971)
- National Institute on Alcohol Abuse and Alcoholism (AA031124)
- Whitehall Foundation
- W. M. Keck Foundation
This publication has 325 references indexed in Scilit:
- Recent advances in applied research on DRO proceduresJournal of Applied Behavior Analysis, 2016
- Safety, tolerability, and pharmacokinetic evaluation of single‐ and multiple‐ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjectsThe Journal of Clinical Pharmacology, 2014
- The role of kappa opioid receptors in stress‐induced reinstatement of alcohol seeking in ratsBrain and Behavior, 2014
- Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization studyJournal of Comparative Neurology, 1994
- Diuretic Effects, Pharmacokinetics, and Safety of a New Centrally Acting Kappa‐Opioid Agonist (CI‐977) in HumansThe Journal of Clinical Pharmacology, 1994
- Ultrastructural analysis of dynorphin B–immunoreactive cells and terminals in the superficial dorsal horn of the deafferented spinal cord of the ratJournal of Comparative Neurology, 1989
- Distribution of dynorphin and enkephalin peptides in the rat brainJournal of Comparative Neurology, 1986
- Multiple opioid receptorsMedicinal Research Reviews, 1981
- A comparison of fenfluramine and amphetamine in manClinical Pharmacology & Therapeutics, 1975
- Apparatus and technique involved in a laboratory method of detecting the addictiveness of drugsJournal of the American Pharmaceutical Association (Scientific ed.), 1955